Evaluation of Whether Deferiprone Affects QT Interval in Healthy Subjects
NCT01860703
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
50
Enrollment
INDUSTRY
Sponsor class
Conditions
Prolonged QTc Interval
Interventions
DRUG:
Deferiprone
DRUG:
deferiprone matching placebo tablets
DRUG:
moxifloxacin
DRUG:
placebo
Sponsor
ApoPharma